Chemkart India IPO Subscribed 0.59x on Day 1

Chemkart India IPO subscribed over 0.59x on its First day of subscription, wherein QIB subscribed 0.80x, NII subscribed 1.46x, and RII subscribed 0.10x.

Table of Contents

Chemkart India’s IPO subscription started on Monday, July 7, 2025, and will close on July 9, 2025, as per the schedule. The price band is set at ₹236 to ₹248 per share with a face value of ₹10. 

Chemkart India IPO Subscription Status

Chemkart India IPO subscribed over 0.59x on its First day till 05.00 PM on 7th July 2025.

  • Chemkart India  IPO subscription QIB investors portion is 0.80x times, while NII subscribed 1.46x times, and RII investors subscribed 0.10x times.  
  • The company has received bids for 12,67,800 shares against 21,51,600 shares on offer on the First day. 
  • Chemkart India’s IPO subscribed over 0.59x times on day 1. 

About Chemkart India IPO

Chemkart India Limited was established in 2015, is one of the leading companies involved in nutritional, Health, and sports supplement products. Its products mostly concentrate on providing health benefits to customers, like nutrition and wellness needs. Chemkart India is based in Mumbai, known to provide a variety of captivated nutritional supplements and components. The company focuses on offering products in 7 categories that include Amino Acids, Health Supplements, Herbal Extract, Nucleotide, Protein, Sports Nutrition, and Vitamin. The company caters to the B2B segment, providing its products to companies that use them to manufacture supplements such as sports supplements, health supplements, vitamins, and protein products. They follow a wide range and customer-first approach that is designed to offer grinding, blending, and packaging services at their hygienic facility in Bhiwandi, Mumbai. The company comprises a 28,259.16 sq. ft. warehouse that is loaded for efficient processing, labeling, and sealing of ingredients. The company includes 40 employees as of March 31, 2025.

Chemkart India IPO Company Financial Report

The company reported revenue of ₹205.46 crores in 2025 against ₹132.83 crores in 2024. The company reported a profit of ₹24.26 crores in 2025 against a profit of ₹14.52 crores in 2024.

Chemkart India IPO GMP

Chemkart India’s IPO GMP was ₹0 as of Monday, 7th July. That indicates the IPO is trading at ₹248 with a ₹0 premium in the grey market against the issue price of ₹248.

Disclaimer: This content is provided strictly for educational and informational purposes. The securities or investments mentioned are not to be considered as investment advice or recommendations. The Investors are advised to do their own research or connect with a financial advisor before making any investment decisions.